BRITANNIA TIGER HEALTH LTD

Company Registration Number:
14702720 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2024

Period of accounts

Start date: 03 March 2023

End date: 31 March 2024

BRITANNIA TIGER HEALTH LTD

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 10

BRITANNIA TIGER HEALTH LTD

Company Information

for the Period Ended 31 March 2024




Director: Sergey Belousov
Igor Zharkov
Registered office: 85
85 Great Portland Street
First Floor
London
England
W1W 7LT
Company Registration Number: 14702720 (England and Wales)

BRITANNIA TIGER HEALTH LTD

Balance sheet

As at 31 March 2024


Notes
13 months to
31 Mar 2024
£
Fixed assets
Tangible assets: 5 1,124
Total fixed assets: 1,124
Current assets
Stocks: 3,000
Debtors: 6 696
Cash at bank and in hand: 15,517
Total current assets: 19,213
Creditors: amounts falling due within one year: 7 ( 5,689 )
Net current assets (liabilities): 13,524
Total assets less current liabilities: 14,648
Total net assets (liabilities): 14,648

The notes form part of these financial statements

BRITANNIA TIGER HEALTH LTD

Balance sheet continued

As at 31 March 2024


Notes
13 months to
31 Mar 2024
£
Capital and reserves
Called up share capital: 100
Profit and loss account: 14,548
Shareholders funds: 14,648

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 15 July 2024
And Signed On Behalf Of The Board By:

Name: Sergey Belousov
Status: Director

Name: Igor Zharkov
Status: Director

The notes form part of these financial statements

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees

    13 months to
    31 Mar 2024
    Average number of employees during the period 0

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 3. Off balance sheet disclosure

    No

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Dividends

13 months to
31 Mar 2024
£
Dividends paid 4,291

dividends paid to S Belousov and I Zharkov

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Tangible assets

Office equipment Total
Cost £ £
Additions 1,124 1,124
Disposals - -
Revaluations - -
Transfers - -
At 31 March 2024 1,124 1,124
Depreciation
Charge for year - -
On disposals - -
Other adjustments - -
At 31 March 2024 - -
Net book value
At 31 March 2024 1,124 1,124

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

6. Debtors

13 months to
31 Mar 2024
£
Prepayments and accrued income 690
Other debtors 6
Total 696

BRITANNIA TIGER HEALTH LTD

Notes to the Financial Statements

for the Period Ended 31 March 2024

7.Creditors: amounts falling due within one year note

13 months to
31 Mar 2024
£
Taxation and social security 4,419
Accruals and deferred income 1,270
Total 5,689